Abstract
新規レストレスレッグス症候群治療薬カバペンチンエナカルビル(レグナイト<sup>&reg;</sup>錠)の薬理学的特徴および臨床試験成績
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have